T1	intervention 0 27	Partial-breast radiotherapy
T2	eligibility 66 99	patients with early breast cancer
T3	duration 123 129	5-year
T4	average-age 795 812	50 years or older
T5	location 780 782	UK
T6	eligibility 813 1077	who had undergone breast-conserving surgery for unifocal invasive ductal adenocarcinoma of grade 1-3, with a tumour size of 3 cm or less (pT1-2), none to three positive axillary nodes (pN0-1), and minimum microscopic margins of non-cancerous tissue of 2 mm or more
T7	control 1146 1187	40 Gy whole-breast radiotherapy (control)
T8	outcome-Measure 1783 1808	ipsilateral local relapse
T9	duration 2264 2301	Between May 3, 2007, and Oct 5, 2010,
T10	No-of-participants 2302 2306	2018
T11	control-participants 2395 2398	674
T12	intervention-participants 2472 2475	673
T13	intervention-participants 2507 2510	669
T14	outcome 2594 2648	5-year estimates of local relapse cumulative incidence
T15	control-value 2654 2658	1·1%
T16	intervention-value 2710 2714	0·2%
T17	intervention-value 2757 2761	0·5%
T18	outcome 2801 2855	Estimated 5-year absolute differences in local relapse
